Results 231 to 240 of about 231,010 (425)

TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

open access: yesMolecular Oncology, EarlyView.
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam   +9 more
wiley   +1 more source

THE POTENTIAL SUPPLY OF CADAVERIC KIDNEYS FOR TRANSPLANTATION

open access: bronze, 1977
Kevin D. Cooper   +2 more
openalex   +1 more source

Enhancing patient engagement in cancer research: a focus on patient‐centric approaches to scientific discovery

open access: yesMolecular Oncology, EarlyView.
Patient engagement involves actively including patients in healthcare decisions and research to ensure care and studies align with their needs. This approach improves outcomes, trust, and communication while fostering collaboration between patients and professionals.
Estela Cepeda   +3 more
wiley   +1 more source

EFFECT OF RBC TRANSFUSION ON CADAVER RENAL ALLOGRAFT SURVIVAL

open access: bronze, 1977
Robert Freeman   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy